ArticleOncotarget2016

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib.

Andrea Casadei Gardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.